Biweekly Long-term Occidiofungin Study for Suppression of Mycotic Recurrence
NCT07521137
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Candidiasis, Vulvovaginal
Interventions
DRUG:
OCF001 Intravaginal Gel
DRUG:
Placebo Gel
Sponsor
Sano Chemicals Inc